Skip to content

October 2019

  • Olive View Internal Medicine Residency

This month's articles take a look back at treatments that have been or are still used, but that don't have the strongest evidence as you might expect.  Here are the landmark articles for treatments used in alcoholic hepatitis and contrast…

Read more

March 2019

  • Olive View Internal Medicine Residency

This month we touch on topics about hypertension and kidney diseases. Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia Clinical Trial of the Effects of Dietary Patterns on Blood Pressure (DASH)

Read more

August 2018

  • Olive View Internal Medicine Residency

This month's articles focus on pharmacotherapy for two common diseases in Cardiology and Nephrology: Heart Failure with Reduced Ejection Fraction (HFrEF) and Diabetic Nephropathy. COMET: Comparing beta-blocker to beta-blocker RENAAL: Addition of Angiotensin II receptor blockers (ARB) to antihypertensive therapy

Read more

Subspecialty Medicine at Olive View

  • Olive View Internal Medicine Residency

You may elect to rotate on a subspecialty service at Olive View, including the core subspecialty rotations as well as additional subspecialties like Endocrinology or Sleep Medicine.  For more information about each subspecialty, select the rotation below. Cardiology Endocrinology Gastroenterology…

Read more
Apr 01 2018

Correction of Anemia with Epoetin Alfa

EBM, Landmark Research

Anemia is a common complication of chronic kidney disease which is typically treated with recombinant human erythropoietin. However the ideal goal hemoglobin is not well established. This study looks to answer if a lower-goal hemoglobin CKD patients shows decreased adverse…

Read more
Back To Top
Login
Log in below to access learning modules.
Forgot Password
Enter your email address or username and we’ll send you instructions to reset your password.